Loading stock data…
$23.66-0.05 (-0.23%)
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
CTEV in the Healthcare sector is trading at $23.66 with a market capitalization of $651M. Wall Street consensus targets $46.00 (5 analysts), implying a +94.4% move over the next 12 months. The stock is currently near its 52-week low of $11.50, remaining 10.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $257.48M↑ | $244.68M↓ | $246.55M↑ | $245.96M↑ | $241.57M |
| Gross Profit | $173.30M↑ | $163.87M↓ | $168.52M↑ | $163.65M↑ | $162.44M |
| Operating Income | $32.97M↑ | $18.47M↓ | $53.63M↑ | $10.07M↓ | $26.32M |
| Net Income | -$59.23M↑ | -$73.56M↑ | -$80.57M↓ | -$69.75M↓ | -$62.64M |
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intel...